Zoersel, Belgium

Marc Joris De Brabander


 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Janssen Pharmaceutica N.V., Tumhoutseweg 30, Beerse, 2340, BE (2006)
  • Zoersel, BE (1988 - 2011)

Company Filing History:


Years Active: 1988-2011

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Marc Joris De Brabander

Introduction

Marc Joris De Brabander, based in Zoersel, Belgium, is a prominent inventor recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of seven patents, he has developed groundbreaking compounds with potential therapeutic applications, particularly in the treatment of inflammation-related diseases.

Latest Patents

Among his latest innovations are two noteworthy patents. The first is for 2,4-disubstituted thiazolyl derivatives, which involves the use of a specific compound of formula (I'). This invention showcases potential applications in medicinal chemistry. The second patent focuses on 2,4,5-trisubstituted thiazolyl derivatives and their anti-inflammatory activity. This invention also includes a compound of formula (I) and outlines the manufacture of a medicament aimed at preventing or treating diseases mediated through TNF-α and/or IL-12. These patents reflect his dedication to advancing medical science through innovative chemical compounds.

Career Highlights

Throughout his career, Marc has made significant strides in the pharmaceutical industry. He has worked with Janssen Pharmaceutica NV, a well-recognized player in the healthcare sector. His work has contributed to the development of novel treatments that address critical medical needs, particularly in inflammatory diseases. His inventive spirit and commitment to research have earned him recognition in his field.

Collaborations

Marc Joris De Brabander has collaborated with esteemed professionals in the pharmaceutical industry, including Jean Pierre Frans Van Wauwe and Nele Vandermaesen. Their combined expertise has fostered an environment of innovation and excellence, enabling the development of therapeutics that can improve patient outcomes.

Conclusion

Marc Joris De Brabander stands out as an influential inventor in the pharmaceutical sector. His innovative patents and collaborative efforts highlight his commitment to advancing healthcare through scientific research. As he continues to explore new frontiers in medicinal chemistry, his contributions will undoubtedly shape the future of therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…